About David Kaplan
Form D filings for Morphoceuticals in 2023 list David Kaplan as promoter.
David Kaplan first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Kaplan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Kaplan works with at each company, as listed on that company's latest Form D.
Morphoceuticals, Inc. · Form D, Jan 23, 2023
AP
Alexander Pickett
Director
ML
Michael Levin
Promoter
DG
David Gill
Executive officer
AK
Amy Kruse
Director
MH
Michael Hufford
Interim Chief Executive Officer and director
RH
Rosemarie Hunziker
Director